Renier J. Brentjens, MD, PhD

About Me

I am a medical oncologist specializing in the treatment of acute and chronic leukemias. My focus on leukemia is, in part, the result of the laboratory research I conduct at Memorial Sloan Kettering Cancer Center. In particular, my laboratory is focused on developing novel treatment approaches for certain leukemias and lymphomas utilizing the patient’s own immune system. Specifically this work involves the genetic manipulation of patients’ immune cells to recognize and kill their own cancer cells. This is a promising form of gene therapy.

Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

In light of encouraging results in mouse studies, we are now testing this approach at Memorial Sloan Kettering in patients with chronic lymphocytic leukemia (CLL) who are no longer responsive to chemotherapy. We hope to set up a similar study for patients with recurrent acute lymphoblastic leukemia in the near future. These highly innovative studies will hopefully result in a novel and successful treatment option for patients with certain forms of hematologic cancers.

  • Clinical Expertise: Adult Leukemias
  • Languages Spoken: English
  • Education: MD, SUNY at Buffalo
  • Residencies: Internal Medicine - Yale-New Haven Hospital
  • Fellowships: Medical Oncology - Memorial Sloan Kettering Cancer Center/Weill Cornell
  • Board Certifications: Internal Medicine; Medical Oncology

My Research

Microscope iconAn icon showing a microscope. View my lab Arrow rightAn icon showing an arrow pointing to the right.

See Renier J. Brentjens’ laboratory
research at Memorial Sloan Kettering.

See My Colleagues

Publications

Visit PubMed for a full listing of Renier J. Brentjens’ journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.

Insurance

Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.